Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide
The difference between pharmaceutical-grade and research-grade peptides cannot be overstated
Although the causes for Parkinsons disease are not completely known, its progression results in a loss of certain neurons in the brain and other alterations that increase oxidative stress
They act as messengers, signaling cells to perform specific functions like healing, hormone production, immune defense, and neurological support
The safety of peptide therapy In theory, pharmaceutical-grade therapeutic peptides are generally safe because peptides already occur in the human body
